Perennial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$226K Buy
862
+3
+0.3% +$769 0.03% 133
2026
Q2
$216K Buy
+859
New +$185K 0.03% 132
2021
Q3
– Sell
-536
Closed -$60K – 81
2021
Q2
$60K Buy
536
+5
+0.9% +$563 0.02% 141
2021
Q1
$57K Buy
531
+411
+343% +$44K 0.02% 141
2020
Q4
$13K Buy
+120
New +$11.5K ﹤0.01% 191
2019
Q1
– Sell
-158
Closed -$15K – 79
2018
Q4
$15K Hold
158
– – 0.01% 145
2018
Q3
$15K Sell
158
-100
-39% -$9.48K 0.01% 154
2018
Q2
$24K Hold
258
– – 0.01% 132
2018
Q1
$24K Sell
258
-42
-14% -$4.61K 0.02% 127
2017
Q4
$29K Buy
300
+200
+200% +$18.8K 0.02% 129
2017
Q3
$9K Hold
100
– – 0.01% 165
2017
Q2
$7K Hold
100
– – 0.01% 181
2017
Q1
$7K Sell
100
-100
-50% -$6.29K 0.01% 160
2016
Q4
$13K Hold
200
– – 0.01% 145

Other funds holding ABBV

Perennial Advisors's ABBV Position: Q3 2026 in Review

Perennial Advisors increased its AbbVie (ABBV) stake by 0.35% in Q3 2026, buying an estimated $769 and bringing the position to 862 shares worth $226K. The position accounts for 0.03% of the portfolio, ranked #133.

Perennial Advisors first reported a position in ABBV in Q4 2016 and has held it in 14 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Perennial Advisors held 862 shares of AbbVie worth $226K as of Q3 2026.
  • Perennial Advisors bought 3 AbbVie shares in Q3 2026, an estimated $769.
  • AbbVie made up 0.03% of Perennial Advisors's portfolio in Q3 2026, its #133 holding.
  • Perennial Advisors first reported a position in AbbVie in Q4 2016 and has held it in 14 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Perennial Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.